Navigation Links
Lori Silver Joins Decision Resources, Inc. as General Counsel
Date:7/24/2008

Formerly of Harvard University's Office of General Counsel, Attorney Will

be Responsible for All Legal Aspects of the Company

WALTHAM, Mass., July 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announced today that Lori Silver has joined the company as General Counsel, responsible for all legal aspects of the company. Ms. Silver comes to Decision Resources with an impressive array of relevant experience, including five years at the Office of the General Counsel of Harvard University, handling litigation, contracts, intellectual property, computer and internet issues and international operations.

Ms. Silver received a B.A. in Political Science from Stanford University and a J.D. from Harvard Law School. Ms. Silver has chaired the Boston Bar Association's Arts, Entertainment & Sports Law Committee and was named one the Boston area's "Rising Star" lawyers by Boston Magazine in 2006 and 2007.

Ms. Silver is responsible for managing all legal issues related to Decision Resources, Inc.'s business, including commercial agreements, intellectual property, employment, licensing and acquisitions.

"We are very excited that Lori has joined our team," said Peter Hoenigsberg, CEO of Decision Resources. "As Decision Resources, Inc. continues to implement an aggressive growth strategy -- both organically and through acquisitions-Lori will be instrumental in helping us achieve our business expansion goals, owing to her wide-range of impressive legal expertise, especially in the areas of intellectual property protection and compliance in general."

About Decision Resources, Inc.

Decision Resources, Inc. is a portfolio of companies that offer best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed, knowledgeable decisions. Decision Resources,
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Paramount Health Care Company Partners With Silverchair Learning Systems
2. Silver-Coated Endotracheal Tubes Cut Down on Infections
3. RealAge Wins Silver PhAME Award
4. Prime Clinical Systems Celebrates Silver Anniversary
5. Resource Systems and Silverchair Learning Systems Launch CareTracker Online Training Module
6. A new way to fight cancer: the silver shield
7. HealthMEDX Partners With Silverchair Learning Systems
8. Seal Shield Introduces New Silver Seal Washable, Antimicrobial Mouse at HiMSS Healthcare Symposium
9. Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard
10. Alexian Brothers Hospital Network Receives American Stroke Associations Get with the Guidelines Silver Achievement Award
11. Epilepsy.com Wins Silver for Best Patient Care/Disease Management Website at the 2007 eHealthcare Leadership Awards - Honored at Healthcare Internet Conference in Las Vegas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... December 15, 2014 Cancer researchers have ... underlying genetic causes of deadly malignant pleural mesothelioma. Surviving ... on their website. Click here to read it ... of Hawaii Cancer Center, and New York’s Langone Medical ... pleural mesothelioma patients in an effort to pinpoint ...
(Date:12/15/2014)... Palm Beach, FL (PRWEB) December 15, 2014 ... Care , knows that holidays can be a daze of ... From slips and falls while decking halls, to burns when ... plenty of holiday hazards that can happen at any time. ... for pain, MD Now has made a list of helpful ...
(Date:12/15/2014)... MA (PRWEB) December 15, 2014 ... management solutions, announced today that it has received ... Quality Assurance (NCQA) for its Disease Management (DM) ... pulmonary disease (COPD), coronary heart disease and diabetes. ... from NCQA for Health Dialog’s Disease Management (DM) ...
(Date:12/15/2014)... December 15, 2014 The increase in prevalence ... of the main factors which is contributing to the growth ... the diagnosis and treatment of hearing loss and balance disorders ... three parts - microphone, speaker and amplifier. The global market ... of 6.01% during the period from 2014 to 2019. Some ...
(Date:12/15/2014)... 2014 In support of high-quality ... to restrictive state laws that may have unintended ... important area of public health policy. , The ... Integrity of Independent Review, contends that state legislation ... peer review determinations can result in subpar outcomes ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... Reporter , MONDAY, Sept. 27 (HealthDay News) -- Implantable ... of thousands of Americans at risk for sudden cardiac ... these medical devices have gotten a bad reputation in ... that connect the ICD to the heart can sometimes ...
... Australia and Hong Kong have conducted a comprehensive study ... of female attractiveness. The study, published in the ... divides young, tall and long armed women were considered ... important determining factor for evolutionary, social and economic success," ...
... their international colleagues have discovered genetic variants that lead ... taking aromatase inhibitors to treat their breast cancer. This ... halt their lifesaving medication. The findings appear today in ... . "Many women stop taking aromatase inhibitors due ...
... HealthDay Reporter , MONDAY, Sept. 27 (HealthDay News) -- ... risk of dying in the hospital and help their doctors ... Hospitals also can use the prediction tool to ... Eric Smith, assistant professor of neurology at the University of ...
... Onconova Therapeutics, Inc. is presenting new data in ... several studies with the company,s radioprotectant Ex-RAD at the ... September 25-29 in Maui, Hawaii. In vivo studies ... increase in survival versus placebo-treated groups in mice exposed ...
... place Jan. 13-16, 2011 at the Wynn Las Vegas. ... (each morning), observing differences in technique from a variety ... Lectures and plenary sessions will cover topics as bladder, ... to treat patients with benign prostate cancer. , Also ...
Cached Medicine News:Health News:New Software for Defibrillators Lowers Risk of Unnecessary Shocks 2Health News:New Software for Defibrillators Lowers Risk of Unnecessary Shocks 3Health News:Unlocking the secret of beauty: Scientists discover the complexities of attractive female bodies 2Health News:Mayo collaboration finds source of breast drug side effect 2Health News:New Tool Helps Predict Stroke Patient's Risk of Death in Hospital: Study 2Health News:New Tool Helps Predict Stroke Patient's Risk of Death in Hospital: Study 3Health News:Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting 2Health News:Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting 3
(Date:12/17/2014)... 2014 With advancements in neurological and ... is seeing new growth, according to Kalorama Information. ... for the majority of market volume, newer 3T ... which are creating opportunities for more sophisticated applications. The ... at a rate of 4%, with world market ...
(Date:12/17/2014)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII ... and commercializing innovative therapies addressing major unmet medical ... in its first Phase 2a study, RXI-109-1301.  The ... 1-month findings that were reported in September of ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , , ...
(Date:12/15/2014)... and Markets ( http://www.researchandmarkets.com/research/bf3b6l/electrocardiogram ) has announced ... Global Trends, Estimates and Forecasts, 2012-2018" report to ... Global Electrocardiogram Devices (ECG) sector is projected ... North America accounts for nearly 36% (2015) ... claims approximately 27% (2018). Asia-Pacific ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4
... Md., Nov. 4, 2010 The U.S. Food ... to treat chronic musculoskeletal pain, including discomfort from ... first used to treat major depressive disorder in ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ...
... Calif., Nov. 4, 2010 ThermoGenesis Corp. (Nasdaq: ... and services that process and store adult stem cells, ... China and Hong Kong for its products used to ... at the point-of-care and in the laboratory. ...
Cached Medicine Technology:FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain 2ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 2ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 3ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 4ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: